Joseph A Kaufman
Examiner (ID: 10129)
Most Active Art Unit | 3754 |
Art Unit(s) | 3752, 3993, 3727, 3754, 3108, 3104 |
Total Applications | 1964 |
Issued Applications | 1543 |
Pending Applications | 181 |
Abandoned Applications | 196 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8152423
[patent_doc_number] => 08168750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Subunits of the adenovirus fiber protein and uses thereof as vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/960932
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 11437
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168750.pdf
[firstpage_image] =>[orig_patent_app_number] => 12960932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/960932 | Subunits of the adenovirus fiber protein and uses thereof as vaccines | Dec 5, 2010 | Issued |
Array
(
[id] => 8814194
[patent_doc_number] => 20130115239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'PROSTATE CANCER DNA VACCINE'
[patent_app_type] => utility
[patent_app_number] => 13/513531
[patent_app_country] => US
[patent_app_date] => 2010-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6460
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513531
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/513531 | PROSTATE CANCER DNA VACCINE | Nov 24, 2010 | Abandoned |
Array
(
[id] => 6000851
[patent_doc_number] => 20110117169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'METHODS AND COMPOSITIONS FOR CAPTURE OF CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/949767
[patent_app_country] => US
[patent_app_date] => 2010-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 21793
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117169.pdf
[firstpage_image] =>[orig_patent_app_number] => 12949767
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/949767 | METHODS AND COMPOSITIONS FOR CAPTURE OF CELLS | Nov 17, 2010 | Abandoned |
Array
(
[id] => 8503329
[patent_doc_number] => 20120302738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'Recombinant antibody vector'
[patent_app_type] => utility
[patent_app_number] => 13/510269
[patent_app_country] => US
[patent_app_date] => 2010-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7530
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510269
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/510269 | Recombinant antibody vector | Nov 15, 2010 | Abandoned |
Array
(
[id] => 5969008
[patent_doc_number] => 20110150861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'SORF CONSTRUCTS AND MULTIPLE GENE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/914556
[patent_app_country] => US
[patent_app_date] => 2010-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 35096
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150861.pdf
[firstpage_image] =>[orig_patent_app_number] => 12914556
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/914556 | SORF CONSTRUCTS AND MULTIPLE GENE EXPRESSION | Oct 27, 2010 | Abandoned |
Array
(
[id] => 9762563
[patent_doc_number] => 08846889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Peptide biosynthesis and pain therapy'
[patent_app_type] => utility
[patent_app_number] => 12/893352
[patent_app_country] => US
[patent_app_date] => 2010-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9744
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12893352
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/893352 | Peptide biosynthesis and pain therapy | Sep 28, 2010 | Issued |
Array
(
[id] => 6055814
[patent_doc_number] => 20110112174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'PEPTIDE BIOSYNTHESIS AND PAIN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/893255
[patent_app_country] => US
[patent_app_date] => 2010-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9736
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112174.pdf
[firstpage_image] =>[orig_patent_app_number] => 12893255
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/893255 | Peptide biosynthesis and pain therapy | Sep 28, 2010 | Issued |
Array
(
[id] => 6096404
[patent_doc_number] => 20110003381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'VIRAL VECTORS AND HOST CELLS AND METHODS OF MAKING AND USING THEM'
[patent_app_type] => utility
[patent_app_number] => 12/883126
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23837
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003381.pdf
[firstpage_image] =>[orig_patent_app_number] => 12883126
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/883126 | VIRAL VECTORS AND HOST CELLS AND METHODS OF MAKING AND USING THEM | Sep 14, 2010 | Abandoned |
Array
(
[id] => 5978289
[patent_doc_number] => 20110071212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'P185NEU-ENCODING DNA AND THERAPEUTICAL USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/874619
[patent_app_country] => US
[patent_app_date] => 2010-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6168
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071212.pdf
[firstpage_image] =>[orig_patent_app_number] => 12874619
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/874619 | p185neu-encoding DNA and therapeutical uses thereof | Sep 1, 2010 | Issued |
Array
(
[id] => 6070633
[patent_doc_number] => 20110045483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Diagnostic Screens for Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 12/870987
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16394
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045483.pdf
[firstpage_image] =>[orig_patent_app_number] => 12870987
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/870987 | Diagnostic screens for Alzheimer's disease | Aug 29, 2010 | Issued |
Array
(
[id] => 8968837
[patent_doc_number] => 08507648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'Detection of truncation mutations by mass spectrometry'
[patent_app_type] => utility
[patent_app_number] => 12/850499
[patent_app_country] => US
[patent_app_date] => 2010-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 39
[patent_no_of_words] => 28435
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12850499
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/850499 | Detection of truncation mutations by mass spectrometry | Aug 3, 2010 | Issued |
Array
(
[id] => 6111296
[patent_doc_number] => 20110189716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'METHOD FOR ANALYZING COLLAGENOUS TISSUES FOR THE DETECTION AND DIAGNOSIS OF BONE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/847408
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19460
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189716.pdf
[firstpage_image] =>[orig_patent_app_number] => 12847408
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/847408 | Method for analyzing collagenous tissues for the detection and diagnosis of bone disease | Jul 29, 2010 | Issued |
Array
(
[id] => 6623685
[patent_doc_number] => 20100311160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/804687
[patent_app_country] => US
[patent_app_date] => 2010-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11012
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311160.pdf
[firstpage_image] =>[orig_patent_app_number] => 12804687
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/804687 | Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom | Jul 25, 2010 | Issued |
Array
(
[id] => 8759870
[patent_doc_number] => 08420389
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Nipah virus vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/839556
[patent_app_country] => US
[patent_app_date] => 2010-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 19
[patent_no_of_words] => 15488
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12839556
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/839556 | Nipah virus vaccines | Jul 19, 2010 | Issued |
Array
(
[id] => 6081806
[patent_doc_number] => 20110143440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Mutations caused by activation-induced cytidine deaminase'
[patent_app_type] => utility
[patent_app_number] => 12/804089
[patent_app_country] => US
[patent_app_date] => 2010-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17811
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20110143440.pdf
[firstpage_image] =>[orig_patent_app_number] => 12804089
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/804089 | Mutations caused by activation-induced cytidine deaminase | Jul 12, 2010 | Abandoned |
Array
(
[id] => 6024365
[patent_doc_number] => 20110052691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Sustained Release Systems and Preparation Method Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/832248
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3889
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12832248
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/832248 | Sustained release systems and preparation method thereof | Jul 7, 2010 | Issued |
Array
(
[id] => 5968974
[patent_doc_number] => 20110150840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'Detection and Treatment of Glyco-Enzyme-Related Disease'
[patent_app_type] => utility
[patent_app_number] => 12/793539
[patent_app_country] => US
[patent_app_date] => 2010-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 25085
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20110150840.pdf
[firstpage_image] =>[orig_patent_app_number] => 12793539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/793539 | Detection and Treatment of Glyco-Enzyme-Related Disease | Jun 2, 2010 | Abandoned |
Array
(
[id] => 7817984
[patent_doc_number] => 20120064604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'METHODS FOR ENHANCING INFECTIVITY OF RETROVIRUSES'
[patent_app_type] => utility
[patent_app_number] => 13/321509
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15575
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064604.pdf
[firstpage_image] =>[orig_patent_app_number] => 13321509
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321509 | Methods for enhancing infectivity of retroviruses | May 17, 2010 | Issued |
Array
(
[id] => 5944053
[patent_doc_number] => 20110104673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY'
[patent_app_type] => utility
[patent_app_number] => 12/755236
[patent_app_country] => US
[patent_app_date] => 2010-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6708
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104673.pdf
[firstpage_image] =>[orig_patent_app_number] => 12755236
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/755236 | NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY | Apr 5, 2010 | Abandoned |
Array
(
[id] => 7489925
[patent_doc_number] => 20110237447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'METHOD OF DETERMINING CHROMATIN STRUCTURE'
[patent_app_type] => utility
[patent_app_number] => 12/754038
[patent_app_country] => US
[patent_app_date] => 2010-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26249
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237447.pdf
[firstpage_image] =>[orig_patent_app_number] => 12754038
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/754038 | METHOD OF DETERMINING CHROMATIN STRUCTURE | Apr 4, 2010 | Abandoned |